top of page
Richard M Fleming, PhD, MD, JD
FlemingMethod
Using the Knowledge Acquired over Two Decades
Differentiating Tissue Based Upon FlemingMethod Measurements of Metabolic & Regional Blood Flow Differences (RBFDs), FlemingMethod (FMTVDM)
Can be Used to Measure Changes in Tissue looking for Infection and Inflammation/Blood Clotting
(InflammoThrombotic Response - ITR)
to the Infection.
.jpg)
Using FlemingMethod 1800 People Were Studied After Becoming Infected with SARS-CoV-2, Measuring Both the Severity of Their COVID-19 Disease and Their Treatment Responses.
Patients Admitted to Hospital with COVID-19 Underwent FlemingMethod in Addition to Other Tests to Measure Tissue COVID-19 Severity and Tissue Response to Treatments.
The Following is the result of FlemingMethod Evaluation of COVID-19 Severity and Treatment Response in One of Those Patients.
FlemingMethod Measurements Showed a Failure of the Patient to Initially Respond to Hydroxychloroquine & Azithromycin. She Responded when Methylprednisolone was Added to her Treatment Regimen.
On 8 September 2022
The first National/International Medical Conference,
The American Society of Nuclear Cardiology,
Released the Results of Published Research
Looking at Successful Treatments for
SARS-CoV-2 and COVID-19
Using FMTVDM/FlemingMethod
Figures Explaining Sites of Drug Effect
bottom of page